The Latest Cardiac and Vascular News
MUNICH, Aug. 27, 2018 /PRNewswire/ — Corvia Medical, Inc., a privately-held company with a first-in-class structural heart device to treat heart failure, today announced one-year follow-up data from the REDUCE LAP-HF I clinical study of its Interatrial Shunt Device (IASD®). The IASD is the world’s first transcatheter device for heart failure with preserved […]
KANSAS CITY, Mo., Aug. 23, 2018 (GLOBE NEWSWIRE) — Cerner, a global leader in health care technology, collaborated with Duke Clinical Research Institute to develop an atherosclerotic cardiovascular disease (ASCVD) Risk Calculator app, designed as a tool to increase communication between the person and their doctor about ways to live […]
KFAR-SABA, Israel–(BUSINESS WIRE)–CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance. The CathWorks FFRangio System is the non-invasive FFR platform that quickly and precisely delivers objective multi-vessel physiologic measurements to cost-effectively optimize and confirm intraprocedural PCI […]
SOUTH SAN FRANCISCO, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) — The Sarcomeric Human Cardiomyopathy Registry (SHaRe) and MyoKardia, Inc. (Nasdaq: MYOK) announced today the publication of results from a multicenter, international, longitudinal study of data from nearly 4,600 patients with hypertrophic cardiomyopathy (HCM), the largest comprehensive HCM cohort assembled to […]
SAN CARLOS, Calif., Aug. 22, 2018 /PRNewswire/ — In a Viewpoint paper published online today in Circulation Research, the Phase III CardiAMP Heart Failure Trial (CardiAMP-HF Trial) studying the investigational CardiAMP stem cell therapyfrom BioCardia®, Inc. (OTC: BCDA) was highlighted as an example of personalized medicine, with promising results from the first 10 patients in the […]
RAMAT GAN, Israel, Aug. 23, 2018 /PRNewswire/ — Dr. David Mishaly, the Director of the Pediatric and Congenital Cardiothoracic Surgery at the Sheba Medical Center, has invented a revolutionary minimally invasive surgical technique used to treat congenital heart defects in children, which boasts a 99% healing rate and 100% aesthetic satisfaction. Dr. Mishaly is the only doctor […]
EDEN PRAIRIE, Minn., Aug. 23, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ: CHFS), today announced it has now completed the transition of all manufacturing activities related to Aquadex FlexFlow® with the initiation of in-house catheter manufacturing at its facility in Eden Prairie, Minnesota. The company previously announced it had commenced […]
CALGARY, Alberta, Aug. 22, 2018 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announced it is supporting a satellite symposium on August 25th, 2018, at the European Society of Cardiology Congress 2018 in Munich, Germany, titled: LDL-c: Done Deal, Next Epigenetics? Satellite Symposium Agenda 15:30 – 15:35 (local […]
MILFORD, Mass.–(BUSINESS WIRE)–RenalGuard Solutions™, Inc., a medical device company focused on innovative fluid management technologies for the cardiac and vascular markets, today announced the treatment of 20,000 patients with RenalGuard® for the prevention of Contrast-Induced Nephropathy (CIN). Contrast-Induced Nephropathy is a form of acute kidney injury (AKI) that affects 10 to […]
AMSTERDAM, Aug. 22, 2018 /PRNewswire/ — Royal Philips (NYSE : PHG , AEX: PHIA), a global leader in health technology, today introduced the EPIQ CVx cardiovascular ultrasound system. Built on the powerful EPIQ ultrasound platform, EPIQ CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients […]
